Stay updated on Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.

Latest updates to the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page
- CheckyesterdayChange DetectedThe site revision tag was updated to v3.5.3, replacing the previous revision v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check23 days agoChange DetectedUpdated the site location from Padua, Italy (35128) to Padova, Italy (35128).SummaryDifference0.0%

- Check37 days agoChange DetectedThe Napoli, Italy, 80131 entry was replaced with Naples, Italy, 80131. The revision label changed from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2; no user-facing content, including study details, was changed.SummaryDifference0.0%

- Check59 days agoChange DetectedRecruitment status updated to Completed; new sites added (West China Hospital, Sichuan University; Institut Gustave Roussy; Hospital Universitario Miguel Servet) and existing site names updated/removed (West China Hospital of Sichuan University; INS Gustave Roussy; Hospital Miguel Servet).SummaryDifference0.3%

Stay in the know with updates to Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.